BridgeMD
New treatment option for Cirrhosis
Official title HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
ClinicalTrials.gov ID: NCT05205954
What this study is testing
- What it's testing
- This research study is evaluating a program that entails a healthcare at home intervention for people with advanced liver disease.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients ≥ 18 years old with diagnosis of cirrhosis based on histology, radiology, and/or elastography presenting to the emergency department...
- Patients must have one of the following:
- Ascites (requiring diuretics or serial large volume paracenteses)
- Hepatic hydrothorax (requiring diuretics)
- Hepatic encephalopathy (requiring medications)
You likely can't join if
- All existing MGB home hospital criteria apply, with the following taking precedent for this specific condition
- History of solid organ transplantation
- On hemodialysis
- MELD score \> 20
- Score \<10 on Simplified Animal Naming Test (S-ANT1)
- Current admission for hemodynamically significant GI bleeding or alcohol withdrawal
See the full eligibility criteria
- Adult patients ≥ 18 years old with diagnosis of cirrhosis based on histology, radiology, and/or elastography presenting to the emergency department or inpatient general medicine service
- Patients must have one of the following:
- Ascites (requiring diuretics or serial large volume paracenteses)
- Hepatic hydrothorax (requiring diuretics)
- Hepatic encephalopathy (requiring medications)
- All existing MGB home hospital criteria apply, with the following taking precedent for this specific condition
- History of solid organ transplantation
- On hemodialysis
- MELD score \> 20
- Score \<10 on Simplified Animal Naming Test (S-ANT1)
- Current admission for hemodynamically significant GI bleeding or alcohol withdrawal
- Require routine administration of controlled substances
- Those deemed ineligible based on the MGH Home Hospital, inpatient medicine or hepatology clinician evaluation
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.